• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 714-728 of 1,261 results

2478 Exhibit: EX2478 Chen, J, Blockbuster Drug What it is, How it works, Investope...

Document IPR2023-00724, No. 2478 Exhibit - EX2478 Chen, J, Blockbuster Drug What it is, How it works, Investopedia, httpswwwinvestopediacomtermsbblockbuster drugasp, last updated Sept 6, 2022 (P...

cite Cite Document

2531 Exhibit: EX2531 Invokamet and Invokamet XR Prescribing Information rev Ju...

Document IPR2023-00724, No. 2531 Exhibit - EX2531 Invokamet and Invokamet XR Prescribing Information rev July 2023 (P.T.A.B. Jan. 17, 2024)

cite Cite Document

1058 Exhibit: Blonde 2012

Document IPR2023-00724, No. 1058 Exhibit - Blonde 2012 (P.T.A.B. Mar. 16, 2023)

cite Cite Document

1104 Exhibit: Exhibit 1104 Vahl

Document IPR2023-00724, No. 1104 Exhibit - Exhibit 1104 Vahl (P.T.A.B. May. 22, 2024)

cite Cite Document

1314 Exhibit: Exhibit 1314 Redacted Vellturo Dep

Document IPR2023-00724, No. 1314 Exhibit - Exhibit 1314 Redacted Vellturo Dep (P.T.A.B. Jun. 21, 2024)

cite Cite Document

2508 Exhibit: EX2508 Novo Nordisk, Financial report for the period 1 January 2021...

Document IPR2023-00724, No. 2508 Exhibit - EX2508 Novo Nordisk, Financial report for the period 1 January 2021 to 30 September 2021 Nov 3, 2021 (P.T.A.B. Jan. 17, 2024)

cite Cite Document

2019 Exhibit: EX2019 Transcript of January 5, 2024 Deposition of William J Jusko, ...

Document IPR2023-00724, No. 2019 Exhibit - EX2019 Transcript of January 5, 2024 Deposition of William J Jusko, PhD (P.T.A.B. Jan. 17, 2024)

cite Cite Document

2458 Exhibit: EX2458 US Food Drug Administration, DrugsFDA, Soliqua 10033

Document IPR2023-00724, No. 2458 Exhibit - EX2458 US Food Drug Administration, DrugsFDA, Soliqua 10033 (P.T.A.B. Jan. 17, 2024)

cite Cite Document

2020 Exhibit: EX2020 Transcript of January 5, 2024 Deposition of William J Jusko, ...

Document IPR2023-00724, No. 2020 Exhibit - EX2020 Transcript of January 5, 2024 Deposition of William J Jusko, PhD (P.T.A.B. Jan. 17, 2024)

cite Cite Document

2538 Exhibit: EX2538 Excerpt of Opening Expert Report of Dr Paul Dalby Regardin...

Document IPR2023-00724, No. 2538 Exhibit - EX2538 Excerpt of Opening Expert Report of Dr Paul Dalby Regarding Invalidity of US Patent No 10,335, 462, In re Ozempic Semag lutide Patent Litigation, N...

cite Cite Document

1312 Exhibit: Exhibit 1312 Redacted Jensen Dep

Document IPR2023-00724, No. 1312 Exhibit - Exhibit 1312 Redacted Jensen Dep (P.T.A.B. Jun. 21, 2024)

cite Cite Document

1150 Exhibit: Exhibit 1150 Park 2007

Document IPR2023-00724, No. 1150 Exhibit - Exhibit 1150 Park 2007 (P.T.A.B. May. 22, 2024)

cite Cite Document

1184 Exhibit: Exhibit 1184

Document IPR2023-00724, No. 1184 Exhibit - Exhibit 1184 (P.T.A.B. May. 22, 2024)

cite Cite Document

1177 Exhibit: Exhibit 1177 Novo Nordisk Annual Report 2023

Document IPR2023-00724, No. 1177 Exhibit - Exhibit 1177 Novo Nordisk Annual Report 2023 (P.T.A.B. May. 22, 2024)

cite Cite Document

1180 Exhibit: Exhibit 1180 David and Stewart

Document IPR2023-00724, No. 1180 Exhibit - Exhibit 1180 David and Stewart (P.T.A.B. May. 22, 2024)

cite Cite Document
<< 1 2 3 4 5 ... 48 49 50 51 52 ... >>